The Complex and Important Cellular and Metabolic Functions of Saturated Fatty Acids by Legrand, Philippe & Rioux, Vincent
ORIGINAL ARTICLE
The Complex and Important Cellular and Metabolic Functions
of Saturated Fatty Acids
Philippe Legrand • Vincent Rioux
Received: 16 February 2010/Accepted: 21 June 2010/Published online: 13 July 2010
 AOCS 2010
Abstract This review summarizes recent ﬁndings on the
metabolism and biological functions of saturated fatty
acids (SFA). Some of these ﬁndings show that SFA may
have important and speciﬁc roles in the cells. Elucidated
biochemical mechanisms like protein acylation (N-myris-
toylation, S-palmitoylation) and regulation of gene tran-
scription are presented. In terms of physiology, SFA are
involved for instance in lipogenesis, fat deposition, poly-
unsaturated fatty acids bioavailability and apoptosis. The
variety of their functions demonstrates that SFA should no
longer be considered as a single group.
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Introduction
Observational studies have shown that high intake of sat-
urated fatty acids (SFA) is positively associated with
increased levels of blood cholesterol and high coronary
heart disease mortality rates [1, 2]. However, more recent
studies have shown inverse association [3, 4], and the
meta-analysis by Siri-Tarino et al. [5] reopened the debate
when writing that ‘‘there is no signiﬁcant evidence for
concluding that dietary saturated fat is associated with an
increased risk of CHD or CVD’’. Without entering this
interesting epidemiological debate on the deleterious
effects of some of saturated fatty acids, it seems that they
can be no longer considered as a single group in terms of
structure, metabolism [6, 7] and cellular function. In this
context, this review will focus only on recent ﬁndings
suggesting that individual SFA possess speciﬁc properties
associated with important biological functions.
New Aspects on the Metabolism of Saturated Fatty
Acids
Cellular Origin of Saturated Fatty Acids
SFA usually account for 30–40% of total FA in animal
tissues, distributed in palmitic acid (15–25%), stearic acid
(10–20%), myristic acid (0.5–1%) and lauric acid (less than
0.5%). Palmitic and stearic acids are universally found in
natural fats. Lauric acid is speciﬁcally abundant in copra
(39–54%) and palmist oils (44–51%). Myristic acid and
short-chain fatty acids (including butyric acid) represent
each about 10% of FA in milk fat. Apart from the dietary
sources, it is well known that the body is capable of syn-
thesizing SFA. Because of their multiple potential origins,
it has been difﬁcult to quantify the real importance of
dietary SFA when compared with endogenous SFA, espe-
cially for palmitic acid. Adipose tissue concentrations of
C15:0, C17:0 but also C14:0 have been used as quantitative
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acid, the amount of its endogenous biosynthesis [9]i s
indeed far smaller than the amounts consumed from dietary
sources (4 g/day in a Swedish population) [10].
Desaturation of Saturated Fatty Acids
Recent ﬁndings on SFA concern their respective capacities
to be desaturated. Every SFA from C12:0 to C18:0 is
converted to its respective monounsaturated product
through the action of D9-desaturase (Stearoyl–CoA desat-
urase, SCD) but with varying efﬁciency. In the rat [11], a
clear increase in hepatic D9-desaturase activity is related to
the carbon chain length, from C12:0 to C18:0. Evidence
was also recently presented that palmitic acid, already
known as a substrate of D9-desaturase, can also be desat-
urated by the mammalian D6-desaturase (Fatty acid
desaturase 2: FADS2) [12]. Palmitic acid D6-desaturation
produces sapienic acid (C16:1n-10) in the preputial gland
of SCD1-/- mice [13] and in human sebaceous glands in
which the expression of SCD is low [14]. The importance
of this human physiological speciﬁcity remains to be
determined.
Speciﬁc Biochemical Functions of Individual SFA
Regulation of Protein Activation by N-terminal
Myristoylation
Myristic and palmitic acids are directly involved in the two
classes of protein fatty acid acylation, N-terminal myris-
toylation and side-chain palmitoylation [15]. Protein
N-myristoylation (Fig. 1) refers to the highly speciﬁc
covalent attachment of myristic acid, by an amide linkage,
to the NH2-terminal glycine residue of increasing number
of eukaryotic and viral proteins [16]. Myristoyl–CoA:
protein N-myristoyltransferase (NMT, EC 2.3.1.97), the
enzyme catalyzing this stable acylation, has been identiﬁed
in many organisms. Genetic advances have revealed that
mammals possess two distinct NMT genes, named type 1
and 2 [17–19]. The contribution of each gene transcript to
NMT expression and activity in vivo, and the speciﬁc role
of each NMT isoform in cellular replication, proliferation,
and other cellular processes, is still under investigation
[20–22]. They both seem to have a similar high substrate
selectivity for myristic acid [17, 19]. The myristoyl moiety
has been shown to mediate protein subcellular localization,
protein–protein interaction or protein–membrane interac-
tions (Fig. 1) required for the biological activities of the
myristoylated proteins [16]. In the myristoylation pathway,
myristic acid therefore exhibits a speciﬁc and important
role for protein activation.
The proteins that are substrates of NMT include key
components in intracellular signaling pathways, onco-
genes, structural viral proteins, and common constitutive
eukaryotic proteins. Computational prediction recently
suggested that about 0.5% of all proteins in the human
genome could be myristoylated [23]. New protein sub-
strates identiﬁed recently in mammals are the tumor
suppressor Fus1 [24], TRIF [25], the sphingolipid D4-
desaturases type 1 and 2 [26], and truncated protein forms
that become substrates after post-translational cleavage by
caspases that reveals an internal myristoylation motif:
BID [27], actin [28], gelsolin [29], and p21-activated
protein kinase 2 [30].
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in the Myristoylation Pathway?
Since endogenous biosynthesis of C14:0 [9] is very low as
compared with dietary sources [10], one can ask if the
amount of free myristic acid could be insufﬁcient to pro-
vide myristoyl–CoA: protein N-NMT with enough co-
substrate. In yeast, studies analyzing the activity of NMT
have suggested that the enzyme was able to use both
exogenous and endogenous myristic acid as the substrate
[31–33]. During the process of the maturation of one pro-
tein, the pool of endogenous free myristoyl–CoA would
probably be sufﬁcient [34]. However, when considering the
pool of myristoylable proteins or the speciﬁc process for
the maturation of viral proteins like Gag or Nef during the
course of a viral, retroviral or lentiviral infection, the
amount of myristoyl–CoA co-substrate needed is consid-
erable [35]. The requirement for myristic acid suggests that
in certain cases, it could be the rate-limiting molecule in
this mechanism or that competition could occur. In addi-
tion, the mechanism by which myristic acid initially
esteriﬁed in the TAG or PL is used for myristoylation is
unknown, too. The available evidence indicates that the
intracellular concentration of free myristic acid in endo-
thelial cells is crucial for the activation of thrombospondin-
1 and could be modulated by its uptake from the medium
through CD36 [36].
Regulation of Protein–Membrane Interactions
by Palmitoylation
Protein palmitoylation refers to the post-translational for-
mation of a thioester linkage between the side-chain of
cysteine and palmitic acid, mainly [37], or other saturated
fatty acids, like myristic and lauric acids [38]. A long time
ago, the ester linkage between saturated fatty acids and
serine or threonine residues was also reported [39], but
since then, this type of linkage has not been described
again.
Palmitoylation is involved in regulatory mechanisms
because the association of the protein with the palmitoyl
moiety is reversible and facilitates protein–membrane
interactions and subcellular trafﬁcking of proteins.
Several signal transductions depend therefore on pal-
mitic acid, including proteins that have been shown to
undergo successive myristoylation and palmitoylation,
like the a subunit of many heterotrimeric G proteins
[40]. Mammalian protein palmitoyltransferases (also
named Protein S-AcylTransferases PAT) are still under
investigation [37]. The recent biochemical evidence of
the PAT activity of a family of proteins that share a
DHHC motif in yeast [41–43] has opened a new ﬁeld of
investigation.
Regulation of Gene Transcription by Saturated Fatty
Acids
While dietary PUFA are known to regulate gene expression
through their inﬂuence on transcription factors (PPAR,
SREBP), the effect of SFA on gene transcription has been
less explored. Lin et al. [44] have shown that SFA (C10:0–
C18:0) strongly elevate the PGC-1b mRNA level, that
co-activates the action of SREBP family of transcription
factors, and consequently increase the transcription of
lipogenic target genes (FAS, SCD-1). Co-activation of the
nuclear receptor LXR/RXR also promotes VLDL secre-
tion. SFA (but also monounsaturated FA) are known to
bind hepatocyte nuclear factor 4 (HNF4). In liver cells,
palmitate and oleate both enhanced the transcription of
glucose-6-phosphatase gene. Palmitate also induced the
recruitment of several transcription factors like NF-jB,
HNF4, CEBPa, and PPARa [45]. SFA, when linked to the
lipid A moiety of lipopolysaccharides, or free, also indi-
rectly induce NF-jB nuclear translocation, activation and
expression of COX-2, and other pro-inﬂammatory cytokines,
through the recently described toll-like receptor 4-derived
signalingpathways[46,47]. Finally, because it is an inhibitor
of the histone deacetylase activity, butyric acid regulates the
expression of several genes, like IL5, by altering the histone
acetylating status of their promoter regions, with conse-
quences for the structure of chromatin [48, 49].
New Demonstrated or Putative Physiological Roles
of SFA
Stearic Acid is Neutral for Cholesterol but Could be
Pro-Lipogenic
As for the other long-chain saturated fatty acids, the health
impact of stearic acid has been studied, showing no deleteri-
ous effect on cardiovascular disease risk [50, 51]. The high
rateofC18:0conversiontoC18:1n-9byD9-desaturationwas
suggested to explain this neutral effect on cholesterol
metabolism, compared to the other SFA [52]. On the other
hand,thedesaturationofdietarystearatetoendogenousoleate
has been described as a stimulating factor for VLDL–TAG
secretion in hepatocytes [53], and an essential step mediating
theinductionoflipogenesis[54]andthepromotionofobesity
[55], showing the very important role of SCD. The evidence
concerning the putative effect of stearic acid on thrombotic
tendency appears inconsistent [56, 57].
Myristic Acid Could Regulate PUFA Bioavailability
It has recently been suggested that myristic acid may be an
activator of the conversion of a-linolenic acid to
Lipids (2010) 45:941–946 943
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myristic acid had a speciﬁc and dose-dependent effect on
D6-desaturase activity [58]. In vivo, when myristic acid
was supplied for 2 months in the diet of rats (from 0.2 to
1.2% of dietary energy), with similar level of dietary
a-linolenic acid (1.6% of FA, 0.3% of energy), a dose–
response accumulation of eicosapentaenoic acid (EPA) was
shown in the liver and plasma [59].
In addition, in humans, compared with a diet containing
0.6% of myristic acid mainly in the sn-2 position in the
TAG, a diet containing 1.2% of myristic acid during a
5-week consumption period signiﬁcantly enhanced EPA
and DHA levels in the plasma PL and DHA level in the
plasma cholesteryl esters [60]. When the intake of myristic
acid increased from 1.2 to 1.8% energy in the same pop-
ulation, EPA, DPA and DHA decreased signiﬁcantly in
plasma PL and EPA also decreased in cholesteryl esters
[61]. This result suggest that, in humans, the effect of
myristic acid on circulating (n-3) PUFA follows a U-
shaped curve with a favorable turning point at around 1.2%
of total daily energy.
So far as potential mechanism(s) of action are con-
cerned, the increase in the activity of D6-desaturase by
myristic acid was ﬁrst postulated to be mediated by
N-myristoylation(seebelow)becausethisenzymeexhibitsan
N-terminal glycine residue. However, we recently demon-
strated that D6-desaturase is not myristoylated in vivo [26].
The hypothesis has been proposed that myristoylation of
another protein of the whole complex of D6-desaturation,
NADH cytochrome b5r e d u c t a s e[ 62], could account for this
increased activity.
Lauric Acid Could be a Precursor for x3 Fatty Acid
Biosynthesis
The low level of C12:0 conversion to C12:1n-3 in the liver
of rats has led to the hypothesis that this monounsaturated
fatty acid of the (n-3) series might be, under extreme
physiological circumstances [for example animals deprived
of (n-3) PUFA in the diet during a long period], an unusual
precursor for the biosynthesis of a-linolenic acid, by suc-
cessive D6-desaturation, elongation, D5-desaturation and
two ﬁnal elongations [11].
SFA May Play Multiple Roles in Early Events
of Apoptosis
Speciﬁc histone deacetylase inhibitors, like butyric acid,
selectively induce cellular differentiation, growth arrest and
apoptosis in a variety of cancer cells [63]. Although contra-
dictory effects have been reported [64], it seems that delivery
ofanadequateamountofbutyratetotheappropriatesitecould
protect against early tumorigenic events [65].
Several SFA may induce apoptosis via different ways.
First, as already suggested above, butyrate and short-chain
S F Am a ya l s oh a v ea ne f f e c to na p o p t o s i s[ 66]. Second,
the pro-apoptotic effect of non-esteriﬁed palmitate and
stearate was shown to require acyl–CoA formation and
NF-jB activation [67]. Third, SFA may also inﬂuence
apoptosis via the ceramide pathway by inducing ceramide
de novo synthesis at several steps [68–70]. The ﬁrst step
catalyzed by the serine palmitoyltransferase involves ser-
ine condensation with palmitoyl–CoA [71]. The last step is
catalyzed by dihydroceramide D4-desaturase (DES). We
recently showed that both DES1 and DES2 isoforms are
myristoylated and that this N-terminal modiﬁcation sig-
niﬁcantly increased the activity of recombinant DES1 in
COS-7 cells [26]. Compared with a recombinant unmyri-
stoylable mutant form of DES1 (N-terminal glycine
replaced by an alanine), the desaturase activity of the
myristoylable wild-type DES1 was two times higher, in
the presence of myristic acid incubated with the cells [26].
The description of this regulatory mechanism highlighted
a new potential relationship between myristic acid, the
saturated fatty acid capable of binding and activating the
enzyme involved in the ﬁnal de novo ceramide biosyn-
thesis step, and lipoapoptosis induced through the cera-
mide pathway. Therefore, we subsequently hypothesized
and showed that the myristoylation of recombinant DES 1
can target part of the enzyme to the mitochondria, leading
to an increase in ceramide levels (speciﬁcally in the
mitochondria) which in turn leads to apoptosis in the COS-
7c e l lm o d e l[ 72].
Medium-Chain Fatty Acids and Fat Deposition
A point of interest is the speciﬁc role played by medium-
chain SFA. It has been reported that overfeeding with a
medium-chain TAG diet in rats results in a diminished
deposition of fat, when compared with rats overfed with
isocaloric long-chain TAG [73]. This suggests an obliga-
tory oxidation of medium-chain SFA in the liver, after
transport via the portal vein, leaving no medium-chain
TAG for accumulation in adipose tissue [73]. Another
hypothesis for medium-chain TAG effect is their inhibitory
effect on apoB synthesis, reducing the VLDL secretion by
hepatocytes. This has been observed with octanoate in
chicken hepatocytes [74].
Conclusion
We have reported here new knowledge on cellular and
physiological functions of the different SFA. For this rea-
son, SFA should no longer be considered as a single group
in terms of structure, metabolism, and function.
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